Atrial Fibrillation New Onset

Cardiovascular
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

GS
Gilead SciencesFOSTER CITY, CA
2 programs
RanolazineN/A1 trial
RanolazineN/A
Active Trials
NCT01590979Terminated54Est. Jun 2015
Elutia
ElutiaSILVER SPRING, MD
1 program
CorMatrix ECM for Pericardial ClosureN/A1 trial
Active Trials
NCT01247974CompletedEst. Dec 2012
Bristol Myers Squibb
1 program
Self-Pulse MonitoringN/A1 trial
Active Trials
NCT05818592Completed526Est. May 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bristol Myers SquibbSelf-Pulse Monitoring
Gilead SciencesRanolazine
ElutiaCorMatrix ECM for Pericardial Closure

Clinical Trials (3)

Total enrollment: 580 patients across 3 trials

NCT05818592Bristol Myers SquibbSelf-Pulse Monitoring

Screening for Atrial Fibrillation With Self Pulse Monitoring

Start: Sep 2020Est. completion: May 2022526 patients
N/ACompleted
NCT01590979Gilead SciencesRanolazine

Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

Start: Apr 2012Est. completion: Jun 201554 patients
N/ATerminated
NCT01247974ElutiaCorMatrix ECM for Pericardial Closure

Evaluation Of New Onset Postoperative Atrial Fibrillation

Start: Dec 2010Est. completion: Dec 2012
N/ACompleted

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
23h ago
From $150K/yr

Associate Regional Clinical Consultant

Johnson & Johnson
Amersfoort, Utrecht, Netherlands
Yesterday

Medical Affairs Sr Scientist- Electrophysiology

Johnson & Johnson
Irvine, California, United States of America
Yesterday
$92K - $148K/yr

Labeling Operations Specialist

Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday

Physician Program Director, Great North

Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday
$132K - $212K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)